Stefano Del Prato
- Estimating the True MACE Benefits From Tirzepatide in SURPASS-CVOT Using an Imputed Placebo Analysis of REWIND
2026/04/06 by Naveed Sattar, Hertzel C. Gerstein, David A. D’Alessio +24 · 1 voice
Medicine · #Atrial Fibrillation Management and Outcomes #Cardiovascular Function and Risk Factors #Peripheral Artery Disease Management